Literature DB >> 10987603

Adenosine-5'-triphosphate test for the noninvasive diagnosis of concealed accessory pathway.

B Belhassen1, R Fish, S Viskin, A Glick, M Glikson, M Eldar.   

Abstract

OBJECTIVES: This study assessed the use of adenosine triphosphate (ATP) in the noninvasive diagnosis of concealed accessory pathway (AP) and dual atrioventricular (AV) node physiology in patients with inducible AV reentrant tachycardia (AVRT).
BACKGROUND: Administration of ATP during sinus rhythm identifies dual AV node physiology in 76% of patients with inducible sustained slow/fast AV nodal reentry tachycardia (AVNRT).
METHODS: Incremental doses of ATP were intravenously administered during sinus rhythm to 34 patients with inducible sustained AVRT involving a concealed AP and to 27 control patients without AP or dual AV node physiology. One study group patient could not complete the study and was excluded from analysis.
RESULTS: The AV reentrant echo beats (AVRE), or AVRT, suggestive of the presence of concealed AP, were observed after ATP administration in 24 (73%) study patients and in none of the control group. Electrocardiographic signs suggestive of dual AV node physiology were observed after ATP administration in 7 (21%) study patients and in none of the control group. Most instances of AVRE/AVRT were preceded by a slight increase (<50 ms) in PR interval. In 8 of 9 patients tested, neither AVRE nor AVRT was no longer observed following ATP administration after successful radiofrequency ablation of the AP. In the remaining patient, a different AVRE due to the presence of an additional AP was observed.
CONCLUSIONS: Administration of ATP during sinus rhythm may be a useful bedside test for identifying patients with concealed AP who are prone to AVRT and those with associated dual AV node pathways.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10987603     DOI: 10.1016/s0735-1097(00)00813-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

1.  Noninvasive diagnosis of cardiac arrhythmias using adenosine compounds.

Authors:  Bernard Belhassen
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-01       Impact factor: 1.468

2.  Use of adenosine test for the exclusion of preexcitation syndrome in asymptomatic individuals.

Authors:  Alon Grossman; Ori Wand; Shlomi Matezki; Arthur Kerner; Amit Assa; Michael Glikson
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-04       Impact factor: 1.468

3.  Adenosine induced PR jump on surface ECG to differentiate atrioventricular nodal re-entrant tachycardia from concealed accessory pathway mediated tachycardia: a bedside test.

Authors:  S C Toal; B U Vajifdar; A K Gupta; A M Vora; Y Y Lokhandwala
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

Review 4.  Proarrhythmic effects of adenosine: a review of the literature.

Authors:  M L Mallet
Journal:  Emerg Med J       Date:  2004-07       Impact factor: 2.740

5.  Role of adenosine/ATP test in supraventricular tachycardia.

Authors:  Johnson Francis
Journal:  Indian Pacing Electrophysiol J       Date:  2003-01-01

6.  Incidence of dual AV node physiology following termination of AV nodal reentrant tachycardia by adenosine-5'-triphosphate: a comparison with drug administration in sinus rhythm.

Authors:  Bernard Belhassen; Roman Fish; Sami Viskin; Aharon Glick; Michael Glikson; Michael Eldar
Journal:  Indian Pacing Electrophysiol J       Date:  2003-01-01

7.  Adenosine-induced sinus tachycardia in a patient with Myotonic Dystrophy type 1.

Authors:  Vincenzo Russo; Gerardo Nigro; Andrea Antonio Papa; Anna Rago; Nadia Della Cioppa; Anna Cristiano; Maria Giovanna Russo
Journal:  Acta Myol       Date:  2014-10

8.  Variation of the PR interval for confirming ventricular pre-excitation on a 12-lead ECG.

Authors:  Sabina Aursulesei; Gelu Simu; Cristian Florea; Paul Boarescu; Cristina Gheorghiu; Florina Frangu; Gabriel Cismaru; Mihai Puiu; Radu Rosu; Dumitru Zdrenghea; Dana Pop
Journal:  Oxf Med Case Reports       Date:  2018-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.